Valeant 4 29

New Valeant Pharmaceuticals Intl Inc Board Sends Message As Firm Reinstates Earnings

The day after what was described as “the most brutal” Senate grilling of a corporate executives in memory, a beat-down involving Valeant Pharmaceuticals, the company restated earnings and materially re-shuffled the board of directors. While the restatement was material, it was the new board members focused on fraud and medical issues that points to the future. For investors, the question going forward is likely to have . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 11/30/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others